By Leanna Gentry, Ph.D., Fellow at Cato Research Clinical trials are a lengthy and costly component of drug development, with the vast majority of drugs failing to ever get to patients. Often, the efficacy seen in preclinical studies does not … Continue reading
The post One and Done: Are single pivotal studies the new norm in cancer therapeutics? appeared first on Ask Cato Research.